by William
M. Murphy, MD, of the University of Florida College of Medicine
"Prostate-Specific Antigen (PSA) and Prostate-Specific Membrane Antigen
(PSMA): Current Benefits and Future Value," by Abdel-Aziz A. Elgamal,
MD, PhD, and Gerald P. Murphy, MD, DSc, of the Pacific Northwest Cancer
Foundation/Northwest Hospital
"Circulating Prostate Cancer Cells Detected by RT-PCR: What Do They
Mean?" by Jose G. Moreno, MD, and Leonard G. Gomella, MD, of the Kimmel
Cancer Center
"Management of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate
Cancer," by Randall Rago, MD, of the H. Lee Moffitt Cancer Center and
Research Institute
"The Current Status of Gene Therapy for Prostate Cancer," by Mohammad
R. Nowroozi, MD, and Louis L. Pisters, MD, of the University of Texas -
M. D. Anderson Cancer Center
The regular departments of
Cancer Control will feature Imaging in
Oncology, Clinical Research Protocols on Prostate Cancer, Imaging in Oncology,
Ten Best Readings on Prostate Cancer, and Pathology Update.
© Copyright 1996 - 2009 H. Lee Moffitt Cancer Center & Research Institute